LYTGOBI

Indicated For

intrahepatic cholangiocarcinoma

About This Medication

# Taiho Oncology Patient Support Patient Guide: How to Get LYTGOBI (futibatinib) at Low or No Cost LYTGOBI (futibatinib) is a prescription medication used to treat certain types of advanced bile duct cancer (cholangiocarcinoma) with specific genetic changes, known as FGFR2 fusions or rearrangements. The **Taiho Oncology Patient Support** program, offered by **Taiho Oncology**, helps eligible patients access LYTGOBI at low or no cost through free medication for uninsured or underinsured patients and co-pay assistance for those with commercial insurance. ## About LYTGOBI (futibatinib) LYTGOBI is an oral targeted therapy approved for adults with previously treated, unresectable, locally advanced, or metastatic intrahepatic cholangiocarcinoma harboring FGFR2 gene fusions or other rearrangements. It works by selectively inhibiting FGFR2, a protein that can drive cancer growth in these genetic subtypes. Your doctor will confirm if you have the right genetic profile through testing before prescribing it. Common side effects include dry mouth, diarrhea, nail toxicity, and fatigue—always discuss these with your healthcare team. This program focuses on affordability, not medical advice; consult your doctor for treatment details.[1][2][3] ## Who Qualifies for the Program? The Taiho Oncology Patient Support program is designed for patients facing financial barriers to LYTGOBI. Key eligibility groups include: - **Uninsured patients**: Those without prescription insurance may qualify for free medication through the patient assistance program (PAP). - **Underinsured patients**: Individuals with insurance but high out-of-pocket costs can get help. - **Commercially insured patients**: Eligible for the **$0 Co-pay Program**, which covers co-pays, deductibles, and out-of-pocket expenses (not valid for government insurance like Medicare, Medicaid, or Medicare Part D).[1][2][3][7] **Important exclusions**: Government-sponsored programs (Medicare Part D, Medicaid, VA, Tricare, etc.) are not eligible for co-pay assistance. Referrals to third-party foundations or Medicare's Low-Income Subsidy (LIS)/Extra Help may be available.[2][7] ## Income Eligibility Breakdown Specific income thresholds (e.g., Federal Poverty Level percentages) are not publicly detailed by Taiho Oncology. Eligibility is assessed case-by-case for uninsured or underinsured patients based on financial need, household income, and other factors. Call **1-844-824-4648** for a personalized review. Here's a general overview: | Household Size | Typical FPL Threshold (Estimated) | Notes | |---------------|----------------------------------|-------| | Individual | Not specified | Case-by-case; proof of need required | | Couple | Not specified | Uninsured/underinsured focus | | Family of 3 | Not specified | Contact program for details | | Family of 4+ | Not specified | Referrals to other resources if needed |[1][3] Since exact limits aren't listed, the program emphasizes flexibility for those who can't afford LYTGOBI otherwise. Spanish-language forms are available.[1][3] ## Insurance Requirements - **Uninsured/Underinsured**: Primary pathway for free LYTGOBI via PAP. - **Commercial/Private Insurance**: Enroll in the Co-pay Program for $0 out-of-pocket (via specialty pharmacy, hospital outpatient, or doctor's office). Program handles benefits investigation, prior authorizations, and appeals.[1][2][5][7] - **Government Insurance**: Not eligible for co-pay help; program offers referrals to LIS/Extra Help or foundations.[2][7] Taiho's team coordinates with pharmacies and provides nurse support for education.[6] ## Step-by-Step Application Process Enrollment is straightforward with multiple options. Work with your doctor, as their involvement is often needed. 1. **Discuss with Your Doctor**: Confirm LYTGOBI prescription and genetic eligibility. Have them complete parts of the Enrollment Form. 2. **Choose Enrollment Method**: - **Download and Fax**: Get the form (English/Spanish) from TaihoPatientSupport.com. Fill it out at your doctor's office, then fax to **1-844-287-2559**.[1][2][5] - **Call for Help**: Dial **1-844-TAIHO-4U (1-844-824-4648)**. Staff assist with enrollment, benefits check, and questions.[1][3][5] - **HCP Portal**: Your healthcare provider can enroll online (requires HCP login/registration).[2] 3. **Submit Required Info**: Include prescription, proof of income/insurance status (details confirmed via phone).[1] 4. **Opt for Extras**: Request nurse navigator for one-on-one support or treatment kits.[5][6][7] 5. **Wait for Confirmation**: Program reviews and notifies you of approval.[1] ## Timeline and Delivery Processing times aren't specified online, but similar programs approve within days to weeks after complete submission. Call for status updates. Approved medication is **shipped directly to you** (or your pharmacy). Refills coordinate automatically; reauthorization may apply based on treatment duration—check with the program.[1][2] ## Alternatives if Denied or Ineligible - **Appeals**: Program assists with insurance appeals.[2][6] - **Third-Party Foundations**: Referrals for co-pay or other aid.[2][7] - **Medicare Extra Help**: For Part D patients.[2][7] - **State Programs**: Generic patient assistance or charity care. - **No Biosimilars**: LYTGOBI has no listed alternatives in the program.[1] Contact **1-844-824-4648** for personalized options. ## Disclaimer This guide is for informational purposes only and based on publicly available program details as of the latest updates. Eligibility, terms, and availability can change—always verify directly with Taiho Oncology Patient Support at **1-844-824-4648** or TaihoPatientSupport.com. Not medical or legal advice. Taiho Oncology reserves the right to modify or end the program. Consult your healthcare provider for treatment decisions. Word count: 1028.

Program information last verified: March 30, 2026